Local adverse reactions | Nadroparin group (n = 152) | Enoxaparin group (n = 113) | Dalteparin group (n = 45) | P value |
---|---|---|---|---|
Total | 92 (60.5%) | 48 (42.5%) | 15 (33.3%) | 0.004a; 0.002b |
Ecchymosis | 28 (18.4%) | 34 (30.1%) | 8 (17.8%) | 0.06 |
Rash | 7 (4.6%) | 0 (0%) | 2 (4.4%) | 0.08* |
Pruritus | 47 (30.9%) | 11 (9.7%) | 3 (6.6%) | < 0.0001a,b |
Red and swollen | 21 (13.8%) | 2 (1.8%) | 1 (2.2%) | < 0.0001a; 0.03b,* |
Induration | 64 (42.1%) | 23 (20.3%) | 6 (13.3%) | < 0.0001a; < 0.001b |